SymBio Pharmaceuticals Revenue

SymBio Pharmaceuticals had revenue of 264.00M JPY in the quarter ending March 31, 2025, a decrease of -55.78%. This brings the company's revenue in the last twelve months to 2.12B, down -54.35% year-over-year. In the year 2024, SymBio Pharmaceuticals had annual revenue of 2.45B, down -56.13%.

Revenue (ttm)

2.12B

Revenue Growth

-54.35%

P/S Ratio

3.68

Revenue / Employee

19.62M

Employees

108

Market Cap

7.79B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	2.45B	-3.14B	-56.13%
Dec 31, 2023	5.59B	-4.42B	-44.15%
Dec 31, 2022	10.01B	1.75B	21.21%
Dec 31, 2021	8.26B	5.27B	176.42%
Dec 31, 2020	2.99B	149.30M	5.26%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Chugai Pharmaceutical	1,222.12B
Daiichi Sankyo Company	1,886.26B
Takeda Pharmaceutical Company	4,581.55B
HOYA Corporation	869.37B
Terumo	1,036.17B
Otsuka Holdings	2,393.18B
Astellas Pharma	1,912.32B
Olympus	997.33B

Revenue Rankings